|
|
|
|
|
 |
|
|
Publications & Resources |
|
Fetus and newborn
Position Statements
Practice Points
Position statements
- FN11-02 Selective serotonin reuptake inhibitors in pregnancy and infant outcomes
- FN11-01 Premedication for endotracheal intubation in the newborn infant (pdf format)
- FN10-01 Safe discharge of the late preterm infant (pdf format)
- FN07-03 Management of the infant at increased risk for sepsis (pdf format)
- FN07-02 Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks’ gestation) (pdf format); Summary (pdf format)
- FN07-01 Prevention and management of pain in the neonate: An update (summary, also available in pdf format). Full statement available in pdf format as well.
- FN06-02 Levels of neonatal care (pdf format)
- FN06-01 Perinatal brachial plexus palsy (pdf format)
- FN05-01 Recommendations for neonatal surfactant therapy (pdf format) (revision in progress)
- FN04-01 Screening guidelines for newborns at risk for low blood glucose (pdf format)
- FN02-02 Red blood cell transfusions in newborn infants: Revised guidelines (pdf format) (revision in progress)
- FN02-01 Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants (pdf format) (revision in progress)
- FN01-02 Guidelines for health care professionals supporting families experiencing a perinatal loss (pdf format)
- FN00-02 Assessment of babies for car seat safety before hospital discharge
- FN97-01 Routine administration of vitamin K to newborns
- FN96-02 Facilitating discharge home following a normal term birth (revision in progress)
- CPS96-01 Prevention of Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effects (FAE) in Canada
- FN96-01 Neonatal circumcision revisited (revision in progress)
- FN94-01 Management of the woman with threatened birth of an infant of extremely low gestational age (revision in progress)
Practice points
Last updated: February 2012
|
|
|
 |
|
|
|
